Skip to content

IGC PHARMA, INC.: filings

Every IGC PHARMA, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q2 2026501410001185185-26-003544
10-Q2026-05-15fiscal Q1 2026501030001185185-26-001885
10-Q2025-11-14fiscal Q2 2026521450001185185-25-001752
10-Q2025-08-14fiscal Q1 2026521070001185185-25-000997
10-K2025-06-27fiscal FY 2025531070001185185-25-000706
10-Q2025-02-14fiscal Q3 2025511430001185185-25-000137
10-Q2024-11-12fiscal Q2 2025511430001185185-24-001096
10-Q2024-08-07fiscal Q1 202548990001185185-24-000766
10-K2024-06-24fiscal FY 2024511030001185185-24-000650
10-Q2024-02-14fiscal Q3 2024451260001185185-24-000160
10-Q2023-11-09fiscal Q2 2024451260001185185-23-001163
10-Q2023-08-10fiscal Q1 202446970001185185-23-000796
10-K2023-07-07fiscal FY 2023501010001185185-23-000693
10-Q2023-02-14fiscal Q3 2023481280001185185-23-000133
10-Q2022-11-01fiscal Q2 2023491300001185185-22-001243
10-Q2022-08-05fiscal Q1 2023501020001185185-22-000890
10-K2022-06-23fiscal FY 2022511030001185185-22-000768
10-Q2022-02-10fiscal Q3 2022481280001185185-22-000162
10-Q2021-10-29fiscal Q2 2022481280001185185-21-001552
10-Q2021-08-11fiscal Q1 202247960001185185-21-001100
10-K2021-06-14fiscal FY 2021501010001185185-21-000802
10-Q2021-02-16fiscal Q3 2021481250001185185-21-000201
10-Q2020-11-20fiscal Q2 2021481250001185185-20-001659
10-Q2020-08-19fiscal Q1 202148960001185185-20-001220
10-K2020-07-13fiscal FY 202049980001185185-20-000984
10-Q2020-02-10fiscal Q3 2020441210001185185-20-000150
10-Q2019-11-06fiscal Q2 2020431150001185185-19-001517
10-Q2019-08-09fiscal Q1 202043900001185185-19-001094
10-K2019-06-14fiscal FY 201943890001185185-19-000890
10-Q2019-02-12fiscal Q3 201936940001185185-19-000224
10-Q2018-10-16fiscal Q2 201938960001185185-18-001848
10-Q2018-08-03fiscal Q1 201939820001185185-18-001341
10-K2018-06-21fiscal FY 201843890001185185-18-001155
10-Q2018-02-20fiscal Q3 2018411110001185185-18-000276
10-Q2017-11-17fiscal Q2 2018411140001185185-17-002428
10-Q2017-08-18fiscal Q1 201842880001185185-17-001802
10-K2017-07-14fiscal FY 201746950001185185-17-001544
10-Q2017-02-21fiscal Q3 2017441180001185185-17-000430
10-Q2016-11-21fiscal Q2 2017441190001185185-16-005839
10-Q2016-08-16fiscal Q1 201743890001185185-16-005260
10-K2016-07-14fiscal FY 201646960001185185-16-004982
10-Q2016-02-16fiscal Q3 2016451200001185185-16-003719
10-Q2015-11-13fiscal Q2 2016431140001185185-15-002954
10-Q2015-08-14fiscal Q1 201643880001185185-15-002205
10-K2015-07-14fiscal FY 201545930001185185-15-001808
10-Q2015-02-12fiscal Q3 2015441160001185185-15-000287
10-Q2014-11-13fiscal Q2 2015441170001185185-14-003021
10-Q2014-08-14fiscal Q1 201545920001185185-14-002203
10-K2014-07-15fiscal FY 201446950001185185-14-001804
10-K2014-07-15fiscal FY 201346950001185185-14-001791
10-Q2014-02-14fiscal Q3 2013421100001185185-14-000346
10-Q2013-11-08fiscal Q2 2013421100001185185-13-002348
10-Q2013-08-16fiscal Q1 201341840001185185-13-001853
10-K2013-07-16fiscal FY 201244900001185185-13-001473
10-Q2013-02-13fiscal Q3 2012451170001185185-13-000299
10-Q2012-11-14fiscal Q2 2012461200001185185-12-002546
10-Q/A2012-08-21fiscal Q1 201246970001185185-12-001906
10-K2012-07-16fiscal FY 201143850001185185-12-001484
10-Q2012-02-16fiscal Q3 201138900001185185-12-000256
10-Q2011-11-18fiscal Q2 2011411040001185185-11-002076
10-Q2011-08-18fiscal Q1 201141810001185185-11-001390

Inspect the source

Entity
IGC PHARMA, INC. / CIK 0001326205
Captured
2026-09-19T11:17:33.392Z
SEC response SHA-256
b5e6159ba110e204ee8261b531c546158153a9053fcdb3ca873d1eff8c2a793e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001326205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))